A health services clinic in Boardman will receive $285,000 as part of new resources U.S. Congressman Greg Walden (R-Hood River) is highlighting to combat the opioid crisis in Oregon.
As part of newly-released grant funding from the Department of Health and Human Services (HHS), Oregon will receive more than $17 million to increase access to a wide range of opioid abuse and addiction treatment services across the state, specifically targeted to rural areas.
“The opioid crisis has hit every community in Oregon and touched millions of families across the country – it truly is the crisis next door,” Walden said. “Combating this epidemic requires an all-hands-on-deck approach, and I applaud the President for taking another important step forward in this fight. These resources will provide critical support to those on the front lines of this fight in Oregon, including the providers at community health centers across our district. This bolsters our efforts in the House to tackle the opioid crisis from all angles with the passage of my legislation, the SUPPORT for Patients and Communities Act. I am continuing to work with my counterparts in the Senate to get a final package to combat the opioid crisis across the finish line and to the President’s desk in the coming weeks.”
The Department of Health and Human Services yesterday awarded more than $1 Billion in opioid-related grants to help combat the opioid epidemic. These grants were awarded in all 50 states.
Included in this grant funding is $396 million for community health centers and rural health programs through HHS’ Health Resources and Services Administration (HRSA). Oregon will receive $6.7 million in funding through HRSA, including $2.2 million for Oregon’s Second District.
Columbia River Community Health Services in Boardman will receive $285,000 through the Community Health Center Grants.
Walden has been part of the effort in Congress to increase and extend funding for community health centers. Walden’s legislation – the SUPPORT for Patients and Communities Act (H.R. 6) – passed the House in June by a bipartisan vote of 396-14.
